Surgical robots named Ravens are flocking to university labs around the U.S. where researchers will be encouraged to hack their software.

This reprogramming could accelerate innovation in surgical robotics, which is stifled due in part to a lock on the market held by the only company with a FDA-approved robot, according to Blake Hannaford, the director of the Biorobotics Laboratory at the University of Washington in Seattle.